Delta Sleep–Inducing Peptide (DSIP) is a naturally occurring neuropeptide that has been studied for its potential role in regulating sleep architecture and neuroendocrine signaling. Synthetic DSIP, including intranasal formulations often referred to as DSIP nasal drip, has been investigated for its ability to influence pathways associated with circadian rhythm, stress adaptation, and restorative sleep processes.

Preclinical research suggests that DSIP may interact with central nervous system signaling involved in sleep modulation, including effects on neurotransmitter balance and hypothalamic-pituitary axis regulation. These mechanisms are believed to contribute to its observed effects in experimental models evaluating sleep quality, stress resilience, and adaptive hormonal responses. Intranasal delivery has been explored as a potential route to support central nervous system exposure in research settings.

Beyond sleep regulation, DSIP has also been studied for its potential role in modulating cortisol balance, emotional stress responses, and overall neuroendocrine homeostasis. Ongoing research continues to evaluate its impact on sleep-related signaling pathways, recovery processes, and systemic regulatory function.